Search

everythinglearnresearchcommunity

for

Search:↓

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Hair loss in women may have causes other than hormones.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Female and male AGA are different diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Spironolactone plus finasteride reduces hirsutism more effectively.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Birth control pills can help reduce mild to moderate acne in women.

EF and PXE not closely related.